Pharmaceutical markets in developed countries may still be quite sizable, but in 2011–12 they were mostly stagnant—or worse. Not so in emerging economies, which are becoming the industry’s best hope for growth.
Articles published in strategy+business do not necessarily represent the views of the member firms of the PwC network. Reviews and mentions of publications, products, or services do not constitute endorsement or recommendation for purchase.
strategy+business is published by certain member firms of the PwC network.